antiplatele, 6) gastric antisecretary, 7) antiallergic, 8) local anaesthetic 9) and benzodiazepine receptor activity. 10) 1,8-Naphthyridines were also reported to be associated with positive ionotropic, 11) b-adrenergic blocking 12) and antihypertensive 13) activities. Aryloxyaminopropanes were reported to posses CNS depressant, 14) neuroleptic, 15) antiarrhythmic, 16) hypotensive 17) and b-adrenergic activity. 18, 19) Therefore, it was envisaged that chemical entities with both 1,8-naphthyridine and aryloxyaminopropane moieties would result in compounds of interesting biological activities.
In the present study, a series of 1,8-naphthyridine derivatives were synthesized. The compounds were characterized by IR, 1 H-NMR spectral and elemental analysis. The compounds were evaluated for anticonvulsant activity at the dose level of 125 and 250 mg/kg by maximal electroshock method, cardiac activity on isolated frog heart and antimicrobial activity against several kinds of gram (ϩ) and gram (Ϫ) bacteria.
CHEMISTRY
Melting points were determined in open capillary tubes and are uncorrected. IR spectra was recorded (in KBr) on Bomem FT-IR spectrophotometer M.B Serial II.
1 H-NMR spectra were recorded on 300 MHz Bruker DPX 200. The 1 H-chemical shifts are reported as parts per million downfield from tetra methyl silane (Me 4 Si). Microanalyses for C, H, N were performed in Heraeus CHN Rapid Analyzer. Analyses indicated by the symbols of the elements are withinϮ0.4% of the theoretical values.
1 H-NMR and IR spectra were consistent with the assigned structures.
Synthesis of 2-Hydroxy-4-methyl-7-amino-1,8-naphthyridine 20) Ethyl acetoacetate (0.1 mol) was added to 2-amino-6-methyl-pyridine (0.1 mol) and heated to 130°C for 1 h. Then, 5 ml of concentrated sulphuric acid was added and heating was continued at 100°C for 30 min. On cooling the reaction mixture, the product was separated out, filtered, dried under vacuum and recrystallized by using methanolether (1 : 1). Yieldϭ37.1%, mp 301-302°C. Synthesis of 2-(3-Chloropropyloxy)-4-methyl-7-amino-1,8-naphthyridine One tenth moles of 2-hydroxy-4-methyl-7-amino-1,8-naphthyridine was added to 0.1 mol (15.7 g, 10.5 ml) of 1-bromo-3-chloropropane in the presence of 15 ml of 10% potassium hydroxide and refluxed for 10 h. On cooling, the product was separated, filtered, dried under vacuum and recrystallized using chloroform-ether (1 : 1 
PHARMACOLOGY
All the synthesized compounds were screened for anticonvulsant activity at the dose of 125 and 250 mg/kg. The anticonvulsant dose was selected between the minimal effective dose and maximal non-lethal dose. All the compounds were soluble in water and administered to the animals as a solution in triple glass distilled water. The compounds were also screened for cardiac activity on isolated frog heart. Wistar albino rats (150-200 g) of either sex were procured from King Institute, Guindy, Chennai. They were kept in colony cages at 25Ϯ2°C, relative humidity 45-55%. under 12 h light and dark cycle. All the animals were acclimatized for a week before use. Small frogs (Rana tigrina, 60-120 g) were procured locally and used on the same day. Unpaired Student-t-test 21) was performed to ascertain the significance of the exhibited anticonvulsant activity of the compounds.
Anticonvulsant Activity 22) The anticonvulsant activity of the synthesized compounds were tested against maximal electroshock induced convulsions in rats. Wistar albino rats (nϭ6) of either sex were selected by random sampling technique. The compounds were administered at the dose level of 125 and 250 mg/kg orally by intragastric tube 30 min prior to an electric shock of 150 mA current for 0.2 s. Diazepam (5 mg/kg, oral) was used as the standard drug. The percentage protection of the compounds is presented in Table 1 .
Cardiac Activity 23) Isolated frog heart was mounted using normal amphibian ringer solution. The effect of the compounds on the rate and force of contraction was observed from 1 to 80 mg. The effect of the compounds at 40 mg concentration with simultaneous administration of adrenaline (10, 20, 30 mg) was also studied (Table 2) .
Antibacterial Activity (Paper Disc Diffusion Method) 24) The antibacterial activity of the synthesized compounds was performed by paper disc diffusion method against gram (ϩ) bacteria (Staphylococcus aureus, Bacillus subtilis, Entero- coccus faecalis and Micrococcus luteus) and gram (Ϫ) bacteria (Proteus vulgaris, Pseudomonas aeruginosa, Escherichia coli and Salmonella typhi). The sterilized (autoclaved at 120°C for 30 min), liquefied nutrient agar (40-50°C) was inoculated (1 ml/100 ml of medium) with the suspension of the microorganism (matched to McFarland barium sulphate standard) and poured into the petri dish to give a depth of 3-4 mm. The paper discs impregnated with the test compounds (1 g/ml in water) were placed on the solidified medium. The plates were refrigerated for two hours at 4°C and then incubated at 37°C for 24 h at the end of which the zone of inhibition was observed.
RESULTS AND DISCUSSION
The protection of the animals against maximal electroshock induced convulsions of the synthesized compounds were screened at the dose levels of 125 and 250 mg/kg. The compounds were screened for cardiac activity using isolated frog heart. The antibacterial activity of the synthesized compounds was tested against gram (ϩ) bacteria (Staphylococcus epidermidis, Bacillus subtilis, Enterococcus faecalis and Micrococcus luteus) and gram (Ϫ) bacteria (Proteus vulgaris, Pseudomonas aeruginosa, Escherichia coli and Salmonella typhi) by paper disc diffusion method.
All the synthesized compounds exhibited significant anticonvulsant activity except 2a. The active compounds exhibited dose dependant anticonvulsant activity. The anticonvulsant activity of 1b, 1d and 2h at the dose of 250 mg/kg were found to be equivalent to Diazepam (5 mg/kg). The anticonvulsant activity of the compounds with respect to 2Ј-hydroxy-7-amino-1,8-naphthridine series (1a-d) was found to be in the order of diphenylaminoϭmorpholinoϾdi-ethanolamino. The anticonvulsant activity of the compounds with respect to 7-amino-1,8-naphthridine series (2a-g) was found to be in the order of p-hydroxyanilinoϾmorpholinoϾ diphenylaminoϾdiethanolamino. The anticonvulsant activity
